Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2

Details for Australian Patent Application No. 2004284496 (hide)

Owner Universiteit Maastricht

Inventors Pinto, Yigal M.

Agent Griffith Hack

Pub. Number AU-B-2004284496

PCT Pub. Number WO2005/040817

Priority 03078161.1 09.10.03 EP

Filing date 27 September 2004

Wipo publication date 6 May 2005

Acceptance publication date 6 August 2009

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040817 Priority application(s): WO2005/040817

6 August 2009 Application Accepted

  Published as AU-B-2004284496

12 November 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 19 Oct 2009. Address for service in Australia - Griffith Hack 167 Eagle Street Brisbane QLD 4000

4 March 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 Oct 2009

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284567-Lenticular image display apparatus

2004284461-Method for twoand three-dimensional microassembly of patterns and structures